Protein hydrolysate versus standard formula for preterm infants
Citation: Ng D.H.C., Klassen J., Embleton N.D., et al. Protein hydrolysate versus standard formula for preterm infants. Cochrane Database of Systematic Reviews 2017, Issue 10. Art. No.: CD012412.
The currently available evidence suggested that feeding preterm infants with hydrolysed formula (rather than standard formula) during their initial hospital admission has no important benefits or harms. his finding is not yet conclusive.
When human milk is not available for feeding preterm infants, protein hydrolysate formulas are often preferred to standard cow’s milk formulas (with intact proteins) as they are perceived as being tolerated better. This review aims to assess the effect of feeding preterm infants with hydrolysed formula (versus standard cow’s milk formulas) on the risk of feed intolerance, necrotising enterocolitis, and other morbidity and mortality in preterm infants.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence the prevention and treatment of malnutrition but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about prevention or treatment of malnutirition on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.